SCHEMBL27504223

SCHEMBL27504223

CC1CC(O)CCN1C(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ PIK3CD O00329 1/20 0.51
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ GRM5 P41594 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ SMO Q99835 2/20 0.43
▸ PDK2 Q15119 1/20 0.43
▸ PLA2G1B P04054 1/20 0.43
▸ ATG4B Q9Y4P1 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19454030 0.85 HPGD (0.64) ACHEGAAHPGDKMT2AMEN1
SCHEMBL19711139 0.84 PIK3CD (0.66) ACHEGAAHPGDPIK3CDPLA2G1B
SCHEMBL12812547 0.79 HPGD (0.75) ACHEGAAHPGDKMT2AMEN1
SCHEMBL8908367 0.78 PIK3CD (0.45) ACHEHPGDPIK3CDGRM5L3MBTL1
SCHEMBL25288173 0.78 ACHE (0.54) ACHEGAAHPGDPIK3CDKMT2A
SCHEMBL25380227 0.78 ACHE (0.54) ACHEGAAHPGDPIK3CDKMT2A
SCHEMBL14645801 0.78 HPGD (0.84) ACHEGAAHPGDKMT2AMEN1
SCHEMBL6688685 0.78 HPGD (0.84) ACHEGAAHPGDKMT2AMEN1
SCHEMBL1102309 0.78 HPGD (0.84) ACHEGAAHPGDKMT2AMEN1
SCHEMBL18194386 0.76 PIK3CD (0.56) ACHEGAAHPGDPIK3CDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1198156-A Process for preparation of 4-methylenepiperidines KAKEN PHARMA CO LTD (JP) 1998-11-04 — — CN disclosed
Send feedback